These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Homocysteine and vascular access thrombosis in end-stage renal disease patients: a retrospective study. Bowden RG, Wyatt FB, Wilson R. J Nephrol; 2002 Dec; 15(6):666-70. PubMed ID: 12495281 [Abstract] [Full Text] [Related]
5. Identifying vascular access complications among ESRD patients in Europe. A prospective, multicenter study. Elseviers MM, Van Waeleghem JP, European Dialysis and Transplant Nurses Association/European Renal Care Association. Nephrol News Issues; 2003 Jul; 17(8):61-4, 66-8, 99. PubMed ID: 12882114 [Abstract] [Full Text] [Related]
8. C-reactive protein predicts vascular access thrombosis in hemodialysis patients. Chou CY, Kuo HL, Yung YF, Liu YL, Huang CC. Blood Purif; 2006 Jul; 24(4):342-6. PubMed ID: 16601326 [Abstract] [Full Text] [Related]
9. High-output cardiac failure secondary to a brachiocephalic arteriovenous hemodialysis fistula: two cases. Young PR, Rohr MS, Marterre WF. Am Surg; 1998 Mar; 64(3):239-41. PubMed ID: 9520814 [Abstract] [Full Text] [Related]
10. Complications of lower extremity arteriovenous grafts in patients with end-stage renal disease. Vogel KM, Martino MA, O'Brien SP, Kerstein MD. South Med J; 2000 Jun; 93(6):593-5. PubMed ID: 10881776 [Abstract] [Full Text] [Related]
11. Some old drugs improve late primary patency rate of native arteriovenous fistulas in hemodialysis patients. Righetti M, Ferrario G, Serbelloni P, Milani S, Tommasi A. Ann Vasc Surg; 2009 Jun; 23(4):491-7. PubMed ID: 18973987 [Abstract] [Full Text] [Related]
14. Trends in hemodialysis vascular access from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2000 to 2005. Moist LM, Chang SH, Polkinghorne KR, McDonald SP, Australia and New Zealand Dialysis and Transplant Registry (ANZDATA). Am J Kidney Dis; 2007 Oct; 50(4):612-21. PubMed ID: 17900461 [Abstract] [Full Text] [Related]
15. IgM-anticardiolipin antibody and vascular access thrombosis in chronic hemodialysis patients. Chuang FR, Chen TC, Yang CC, Cheng YF, Hsu KT, Lee CH, Lin CL, Wang IK, Chang HW, Wang PH. Ren Fail; 2005 Oct; 27(1):25-30. PubMed ID: 15717631 [Abstract] [Full Text] [Related]
16. The multidisciplinary approach to hemodialysis vascular access at the Mount Sinai Hospital. Vassalotti JA, Falk A, Teodorescu V, Uribarri J. Mt Sinai J Med; 2004 Mar; 71(2):94-102. PubMed ID: 15029401 [Abstract] [Full Text] [Related]
18. A challenge for nephrologists--increasing fistula maturation rates, reducing fistula maturation time, and decreasing dialysis catheter prevalence in the United States. Levine MI. Semin Dial; 2008 Mar; 21(3):280-4. PubMed ID: 18533969 [Abstract] [Full Text] [Related]
19. Thrombophilia and the risk for hemodialysis vascular access thrombosis. Knoll GA, Wells PS, Young D, Perkins SL, Pilkey RM, Clinch JJ, Rodger MA. J Am Soc Nephrol; 2005 Apr; 16(4):1108-14. PubMed ID: 15728780 [Abstract] [Full Text] [Related]
20. [How to predict thrombosis of arteriovenous fistule?]. Kapun S, Zibar L. Acta Med Croatica; 2008 Feb; 62(1):9-13. PubMed ID: 18365494 [Abstract] [Full Text] [Related] Page: [Next] [New Search]